Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109527619 | 10952761 | 9 | F | 20150615 | 20160628 | 20150325 | 20160708 | EXP | BR-PFIZER INC-2014038485 | PFIZER | 71.00 | YR | M | Y | 77.00000 | KG | 20160708 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 109527619 | 10952761 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG, ONCE DAILY, CYCLE (2 PER 1) | Y | U691A | 21938 | 50 | MG | CAPSULE, HARD | |||||
| 109527619 | 10952761 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | UNK | Y | V437G | 21938 | CAPSULE, HARD | ||||||||
| 109527619 | 10952761 | 3 | SS | SUTENT | SUNITINIB MALATE | 1 | UNK | Y | Z597A | 21938 | CAPSULE, HARD | ||||||||
| 109527619 | 10952761 | 4 | C | EUTHYROX | LEVOTHYROXINE SODIUM | 1 | UNK | 0 | |||||||||||
| 109527619 | 10952761 | 5 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 2 IN THE MORNING AND 2 AT NIGHT | 0 | 2 | DF | BID | ||||||||
| 109527619 | 10952761 | 6 | C | INSULIN HUMAN | INSULIN HUMAN | 1 | 20MG AND 14MG AT NIGHT | 0 | 34 | MG | QD | ||||||||
| 109527619 | 10952761 | 7 | C | CENTRUM SILVER /02363801/ | MINERALSVITAMINS | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 109527619 | 10952761 | 1 | Metastatic renal cell carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 109527619 | 10952761 | HO |
| 109527619 | 10952761 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 109527619 | 10952761 | Anaemia | |
| 109527619 | 10952761 | Diarrhoea | |
| 109527619 | 10952761 | Flatulence | |
| 109527619 | 10952761 | Haemoglobin decreased | |
| 109527619 | 10952761 | Haemorrhage | |
| 109527619 | 10952761 | Influenza | |
| 109527619 | 10952761 | Musculoskeletal chest pain | |
| 109527619 | 10952761 | Nausea | |
| 109527619 | 10952761 | Pain | |
| 109527619 | 10952761 | Pollakiuria | |
| 109527619 | 10952761 | Prostatic dysplasia | |
| 109527619 | 10952761 | Prostatic specific antigen increased | |
| 109527619 | 10952761 | Pyrexia | |
| 109527619 | 10952761 | Rash macular | |
| 109527619 | 10952761 | Skin papilloma | |
| 109527619 | 10952761 | Tooth pulp haemorrhage | |
| 109527619 | 10952761 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 109527619 | 10952761 | 1 | 20130102 | 0 | ||
| 109527619 | 10952761 | 2 | 20160601 | 0 | ||
| 109527619 | 10952761 | 5 | 2010 | 0 | ||
| 109527619 | 10952761 | 6 | 2004 | 0 |